Evaluation and Management of Left Adnexal Fullness on CT
When left adnexal fullness is identified on CT, the next step is transvaginal ultrasound combined with transabdominal ultrasound for definitive characterization—CT is not appropriate for further evaluation or follow-up of adnexal findings 1.
Why Ultrasound is the Definitive Next Step
The ACR Appropriateness Criteria explicitly states that CT pelvis (with or without contrast) is "usually not useful" for characterization or follow-up of adnexal masses because the roles of ultrasound and MRI are well-established 1. CT lacks the resolution and specificity needed to properly risk-stratify adnexal lesions.
The Ultrasound Approach
Transvaginal ultrasound combined with transabdominal technique is the gold standard because:
- Transvaginal component provides detailed evaluation of adnexal structures
- Transabdominal component captures larger lesions that may extend beyond transvaginal field of view
- Color/power Doppler must be included to assess vascularity of any solid components 1
Risk Stratification Systems to Apply
Once ultrasound is performed, use standardized reporting systems 1:
- O-RADS (Ovarian-Adnexal Reporting and Data System): Demonstrates 96.8% sensitivity for malignancy with 92.8% specificity
- SRU (Society of Radiologists in Ultrasound) consensus guidelines: Shown to decrease unnecessary follow-up of benign lesions while maintaining high sensitivity for malignancy
- IOTA simple rules: Slightly lower sensitivity (92.1%) but comparable specificity (93.2%)
These systems evaluate:
- Lesion size and locularity
- Presence, size, and number of solid components
- Degree of internal vascularity
- Classical benign features (simple cyst, dermoid, endometrioma)
When MRI is Indicated
MRI pelvis with and without IV contrast becomes the alternative imaging modality only when 1:
- The lesion cannot be adequately characterized on ultrasound
- The mass is indeterminate on initial ultrasound
- Ultrasound surveillance is technically inadequate
Contrast-enhanced MRI is superior to both ultrasound and noncontrast MRI for detecting internal enhancing soft tissue components—the key feature distinguishing benign from malignant lesions 1.
Critical Pitfall to Avoid
Do not obtain additional CT imaging for adnexal evaluation 1. This exposes patients to unnecessary radiation, costs, and does not provide the tissue characterization needed for proper management. The evidence is clear that CT has no role in benign mass follow-up or characterization of indeterminate lesions when ultrasound and MRI are available.
Simple Cysts: The Exception
If the CT report describes a simple cyst (unilocular, thin-walled, no solid components), recent evidence shows these carry near-zero malignancy risk regardless of size or menopausal status 1, 2. The absolute 3-year ovarian cancer risk is 0-0.5 cases per 10,000 women—not different from women with normal ovaries. Updated SRU guidelines now recommend follow-up only for simple cysts >3 cm in postmenopausal women (or >5 cm if exceptionally well-visualized) 1.
Bottom Line Algorithm
- Order transvaginal + transabdominal ultrasound with Doppler as the immediate next step
- Apply O-RADS or SRU classification based on ultrasound findings
- If indeterminate on ultrasound → proceed to MRI pelvis with and without contrast
- If simple cyst criteria met → follow SRU size thresholds for surveillance vs. reassurance
- Never order additional CT for adnexal characterization or follow-up